Trust & Quality

Certified Excellence

Patents, awards and independent laboratory testing — transparency in every detail.

ZL201210517035.3

Invention Patent

SMT Nano-Scale Micro-Molecule Active Peptide — China Invention Patent Certificate ZL201210517035.3

Nano-Scale Micro-Molecule Active Peptide Technology

SMT nano-scale micro-molecule active peptide — produced through enzymatic hydrolysis powered by a patented collagenase-producing strain (China invention patent).

SMT Peptides · Case No. 1906-02870

A granted invention patent means the core technology has passed a strict examination of novelty, inventiveness and practical applicability.

Recognised for Wellness Innovation

2024 Honouree SMT 2024 Technology for Good Award Certificate

Technology for Good2024 Award Honouree

Recognised at the 2024 Technology for Good awards for bringing science-backed cellular wellness to communities.

Official Award Page ↗
Channel 8 SMT 2024 Award Ceremony

2024 Channel 8 SingaporeRecognised for wellness innovation

Honoured at the Channel 8 Singapore awards for innovation in wellness.

Channel 8 Official Site ↗

Why These Credentials Matter

TÜV SÜD PSB

An independent German testing body verified the amino acid profile and heavy metal safety (As/Cd/Pb/Hg <0.1 ppm, within HSA limits).

SGS

One of the world's largest testing and certification organisations issued the quality test report for the nano-active peptide.

COA

The Certificate of Analysis confirms the composition and quality of each batch of nano-active peptide.

MSDS

The Material Safety Data Sheet (UN GHS Rev.9) documents safe handling, storage and transport information.

China Invention Patent

ZL201210517035.3 protects the collagenase-producing strain at the heart of SMT’s nano-peptide production — the core of what makes SMT different.

Refined Over a Decade of Research

SMT is the result of more than 12 years of continuous research — from a single deep-sea strain to a precision nano-peptide.

12+ Years of R&D

Patented in 2012 and officially launched in 2019 — the technology behind SMT was refined for more than a decade before reaching the market.

Academic Collaboration

Research partnership with Changchun University of Chinese Medicine and the Jilin Provincial Ginseng Science Research Institute.

Published Research

Peer-reviewed paper on the PI3K-Akt signalling pathway in insomnia, first published online in the Chinese Journal of Hospital Pharmacy (2024).

Precision Nano-Peptide

2–4 peptide chains with ≥99% below 1000 Da and total amino acid content of 99.21% — verified by independent laboratories.